Skip to main content

Table 1 Comprehensive evaluation of 14 patients with molecular confirmation of GD

From: GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia

Pt

DBS value (pmol/punch−1/h−1)

Conventional enzymatic assay

Lyso-Gb1 (ng/mL)

Genotype

Phenotype

Leucocytes (nmol/mg/h)

Lymphoblasts (nmol/mg/h)

1

1.10

1.20

0.40

1921.9

p.Leu483Pro/p.Asp448His

GD3

2

1.19

1.30

NA

NA

p.Leu483Pro/p.Leu483Pro

GD3

3

0.00

1.50

NA

NA

c.115+1G>A/p.Asn227Ser

GD1

4

0.70

1.80

NA

2538.3

p.Asn409Ser/c.115+1G>A

GD1

5

0.90

0.90

NA

1087

p.Asn409Ser/G202R

GD1

6

3.50

7.2

NA

441

p.Asn409Ser/p.Leu483Pro

GD1

7

0.60

NA

1.07

546.8

p.Asn409Ser/p.Asn409Ser

GD1

8

1.19

NA

2.90

NA

p.Ser310Gly/p.Gly234Trp

GD1

9

1.30

4.00

NA

1017.5

p.Asn409Ser/p.Asn409Ser

GD1

10

1.40

1.50

NA

NA

p.P138Lfs*62/p.Asn409Ser

GD1

11

1.30

NA

NA

NA

p.Asn409Ser/p.Asn409Ser

GD1

12

0.90

NA

0.50

328

p.Asn409Ser/p.Arg86*

GD1

13

0.67

NA

NA

NA

p.Asn409Ser/p.Leu483Pro

GD1

14

3.15

NA

NA

1255.9

c.115+1G>A/p.Asn409Ser

GD1

  1. Pt patient, NA not available, GD1 Gaucher disease subtype 1, GD3 Gaucher disease subtype 3